Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease

NCT00006077 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00006077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2000
Completion date
July 31, 2003
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease